ANI Pharmaceuticals, Inc. (ANIP)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 65.88 |
| Open | 70.00 |
| Bid | 67.81 x 200 |
| Ask | 68.18 x 100 |
| Day's Range | 64.05 - 70.00 |
| 52 Week Range | 38.91 - 70.81 |
| Volume | |
| Avg. Volume | 151,787 |
| Market Cap | 1.428B |
| Beta (5Y Monthly) | 0.81 |
| PE Ratio (TTM) | 80.06 |
| EPS (TTM) | 0.85 |
| Earnings Date | May 10, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 79.80 |
GuruFocus.comANI Pharmaceuticals Reports Strong Q1 2024 Results, Surpassing Revenue Expectations
Highlights Include Record Net Revenues and Robust Growth in Rare Disease Segment
ZacksNektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
Nektar (NKTR) reports a narrower-than-expected loss in the first quarter of 2024 and tops revenue estimates.
ZacksInsmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
Insmed (INSM) Q1 earnings beat estimates while sales miss the mark. Management posts positive data readouts from mid-stage studies on its experimental inhalation powder in PH-ILD and PAH indications.
© 2024 Yahoo. All rights reserved.